- Home
- DNLI vs IHS Comparison
DNLI vs IHS Comparison
Compare DNLI & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | IHS |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DNLI | IHS |
|---|---|---|
| Price | $21.69 | $8.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $34.27 | $8.29 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 05-05-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.26 |
| Revenue Next Year | $444.50 | $7.87 |
| P/E Ratio | ★ N/A | $5.85 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.31 | $4.68 |
| 52 Week High | $23.77 | $8.95 |
Technical Indicators
Market Signals| Indicator | DNLI | IHS |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 55.49 |
| Support Level | $18.86 | $8.01 |
| Resistance Level | $22.21 | $8.34 |
| Average True Range (ATR) | 1.14 | 0.06 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 75.42 | 51.52 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria and Sub-Saharan Africa. The majority of its revenue is derived from Nigeria.